Why GLP-1s Are Helping The Hair Care Industry
GLP-1 weight loss drugs are causing hair loss in many users, creating a significant business opportunity for the hair care industry. The hair loss is attributed not to the drugs directly, but to the rapid weight loss and nutritional deficiencies they cause. By 2030, an estimated 25 million Americans will be on GLP-1 medications, expanding the market further.
Summary
GLP-1 weight loss drugs, while helping millions of Americans shed pounds, are producing a notable side effect: hair loss. This has opened what industry experts are calling a 'category reset' worth approximately $1 billion for the hair treatment industry. One GLP-1 user interviewed for the segment described her previously thick hair falling out in clumps after about a year on the medication.
According to Accenture's global beauty lead, hair loss is among the most significant side effects the beauty industry is monitoring, particularly as GLP-1 drugs become more accessible. Crucially, the hair thinning is not caused by the drugs themselves but by the rapid weight loss they induce, which shocks the body and creates nutrient deficiencies. Both Novo Nordisk and Eli Lilly have acknowledged hair loss as an identified risk associated with their respective GLP-1 products.
The scale of the opportunity is substantial. Currently about 1 in 8 U.S. adults report taking a GLP-1, and that number is projected to grow from 5 million in 2023 to 25 million by 2030. GLP-1 users tend to spend about 30% more on beauty products and represent a sticky consumer base, since hair treatment results take months to appear, encouraging long-term purchasing.
Major brands are responding aggressively. Redken, owned by L'Oreal, launched a hair treatment line specifically tested on GLP-1 users. Nutrafol is reporting increased demand for its hair growth supplements, and KeraFactor claims 100% year-over-year growth in its direct-to-consumer store driven by GLP-1 user interest. Ulta Beauty also noted increased consumer purchases of hair treatment products tied to the GLP-1 trend.
Broader industry trends are reinforcing this shift. Since the pandemic, consumers have been gravitating toward science-backed, clinically-proven, and dermatologist-endorsed products — a movement that started in skincare and is now migrating into haircare. Experts suggest the winning brands will be those that combine scientific credibility with aesthetic appeal. On a personal note, the individual featured in the story did eventually experience hair regrowth, though it required multiple products, years of effort, and considerable experimentation.
Key Insights
- Accenture's global beauty lead argues that GLP-1-induced hair loss is caused not by the drugs themselves but by the rapid weight loss, which shocks the body and creates nutrient deficiencies — distinguishing the root cause as metabolic rather than pharmacological.
- Industry analysts characterize GLP-1 users as a uniquely valuable consumer segment, claiming they spend about 30% more on beauty products and represent long-term customers because hair treatment results take months to appear, naturally extending purchasing cycles.
- KeraFactor reported 100% year-over-year growth in its direct-to-consumer store attributed to increased interest from GLP-1 users, while Redken created an entire hair treatment line specifically tested on GLP-1 users — signaling that brands are moving beyond general positioning to GLP-1-specific product development.
Topics
Full transcript available for MurmurCast members
Sign Up to Access